These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma. Metzger AL; Singer FR; Bluestone R; Pearson CM N Engl J Med; 1974 Dec; 291(24):1294-6. PubMed ID: 4215021 [No Abstract] [Full Text] [Related]
3. Appearance of a gastric ulcer during diphosphonate therapy in a woman with CRST syndrome. Saunders RL South Med J; 1977 Nov; 70(11):1327-9. PubMed ID: 411174 [TBL] [Abstract][Full Text] [Related]
4. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876 [No Abstract] [Full Text] [Related]
5. Etidronate ameliorates painful soft-tissue calcification in Werner syndrome. Honjo S; Yokote K; Takada A; Maezawa Y; Kobayashi K; Tokuyama T; Sonezaki K; Saito Y J Am Geriatr Soc; 2005 Nov; 53(11):2038-9. PubMed ID: 16274399 [No Abstract] [Full Text] [Related]
6. Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment. Smith R; Russell RG; Woods CG J Bone Joint Surg Br; 1976 Feb; 58(1):48-57. PubMed ID: 818090 [TBL] [Abstract][Full Text] [Related]
7. Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy. Mori H; Okada Y; Yamaoka K; Saito K; Tanaka Y J Bone Miner Metab; 2012 Jan; 30(1):114-8. PubMed ID: 21710176 [TBL] [Abstract][Full Text] [Related]
8. Proceedings: Use of diphosphonates in diseases associated with ectopic calcification. Sheppard H; Uttley WS; Syme J; Belton N Arch Dis Child; 1974 Oct; 49(10):828. PubMed ID: 4215374 [No Abstract] [Full Text] [Related]
9. [Regression of severe periarticular calcifications during treatment with bisphosphonate in a dialysis patient]. Obad D; Larsen NA; Pedersen EB Ugeskr Laeger; 2010 Mar; 172(9):719-21. PubMed ID: 20199755 [TBL] [Abstract][Full Text] [Related]
10. [Diphosphonate (disodium etidronate) lowers cholesterol and total lipid levels in the blood of humans]. Caniggia A; Gennari C; Picchi M Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1416-22. PubMed ID: 4218488 [No Abstract] [Full Text] [Related]
11. Calcinosis cutis and Sjögren's syndrome. Llamas-Velasco M; Eguren C; Santiago D; García-García C; Fraga J; García-Diez A Lupus; 2010 May; 19(6):762-4. PubMed ID: 20156928 [TBL] [Abstract][Full Text] [Related]
17. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment. Smith R; Russell RG; Bishop MC; Woods CG; Bishop M Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518 [No Abstract] [Full Text] [Related]
18. Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects. Hashiba H; Aizawa S; Tamura K; Kogo H Ther Apher Dial; 2006 Feb; 10(1):59-64. PubMed ID: 16556138 [TBL] [Abstract][Full Text] [Related]
19. [Influence of disodium etidronate (EHDP) on plasma and urinary levels of sodium and potassium in humans]. Gennari C; Orlandini GA; Nuti R; Francini G Boll Soc Ital Biol Sper; 1975 Jul; 51(14):873-7. PubMed ID: 814911 [No Abstract] [Full Text] [Related]
20. Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients. Stover SL; Niemann KM; Miller JM J Bone Joint Surg Am; 1976 Jul; 58(5):683-8. PubMed ID: 819446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]